Endocrinology
Research conducted in Switzerland has shed light on the role of complexin I (CPX I) in regulating glucose-induced secretion in pancreatic beta-cells. The study, published in the Journal of Cell Science, found that CPX I plays a critical role in controlling the stimulated-exocytosis of insulin. The researchers discovered that pancreatic
Endocrinology
Scientists in Germany have made a groundbreaking discovery that inactivating the glucocorticoid receptor (GR) in hepatocytes leads to fasting hypoglycemia and ameliorates hyperglycemia in diabetes. This finding has significant implications for the treatment of diabetes mellitus, as it suggests that liver-specific glucocorticoid antagonists could be beneficial in controlling diabetic hyperglycemia.
Endocrinology
Researchers in Japan have discovered that recombinant hepatocyte growth factor (HGF) significantly accelerates cutaneous wound healing in a diabetic mouse model. The study found that topical administration of HGF, along with basic fibroblast growth factor (bFGF), promoted wound closure and re-epithelialization. Notably, HGF treatment enhanced expansion of granulation tissue, stimulated
Endocrinology
Researchers are working to enhance bioengineered surrogate beta cells for diabetes therapy, which aims to replace or replicate insulin-producing cells in the pancreas. Insufficient pancreatic beta-cell mass is a fundamental cause of both type 1 and 2 diabetes, highlighting the need for new sources of insulin-producing cells. Bioengineering techniques can
Endocrinology
Researchers in the Peoples Republic of China have made significant progress in preventing type I diabetes in murine models through the use of recombinant gene therapy. According to a study published in Gene Therapy, scientists used a recombinant adenovirus containing the human CTLA4-FasL gene (AdCTLA4-FasL) to treat mice with autoimmune
Endocrinology
Investigators have highlighted the critical role of surgical revascularization in managing diabetic foot wounds, a common complication in patients with diabetes. According to a study, approximately 15% of patients with diabetes develop diabetic foot wounds, which often result from a combination of neuropathy, impaired wound healing, and peripheral arterial occlusive
Endocrinology
A groundbreaking study on over 2,000 children of women with gestational diabetes has revealed that maternal obesity is a more decisive factor in the occurrence of congenital malformations than the severity of the diabetes itself. Researchers from the Universitat Autonoma de Barcelona and l'Hospital de Sant Pau
Endocrinology
A new study has found that postmenopausal hormone therapy can promote cardiovascular disease in women with diabetes or pre-diabetes, despite improving their cholesterol levels, fasting glucose, and insulin resistance. The study, reported in the June 29, 2004, issue of Circulation, used angiography to document the progression of atherosclerosis in postmenopausal
Endocrinology
A 65-year-old diabetic patient was diagnosed with chronic inflammatory demyelinating polyneuropathy (CIDP) after being infected with Campylobacter jejuni, which led to symptoms mimicking vasculitic mononeuritis multiplex. The patient's treatment with intravenous immunoglobulins was successful, and this case report suggests that CIDP should be considered as a potential diagnosis
Endocrinology
Research conducted at Case Western Reserve University has found that gestational diabetes mellitus (GDM) does not alter metabolic processes in obese pregnant women. The study, published in the American Journal of Physiology-Endocrinology and Metabolism, investigated changes in energy expenditure and fat accretion in women with normal glucose tolerance (NGT) and
Endocrinology
Researchers have discovered a novel approach to preventing autoimmune diabetes in mice by co-delivering pro-apoptotic BAX with a DNA vaccine. According to a study published in Vaccine, the co-delivery of BAX with a DNA vaccine encoding glutamic acid decarboxylase (GAD) significantly prevented the onset of diabetes in non-obese diabetic (NOD)
Endocrinology
Researchers have successfully re-expressed the estrogen receptor alpha (ERα) in estrogen-negative breast cancer cells, recreating a hormone-responsive phenotype. This breakthrough opens up new therapeutic possibilities for the treatment of this aggressive form of cancer. Using a tetracycline-regulated gene expression system, investigators transfected the human wild-type ERα into the MDA-MB-231 breast
